The expression of MRPL52 is upregulated in breast cancer, particularly in hypoxic breast cancer cells, which regulates the ROS/Notch1/Snail signaling pathway to promote EMT, migration, and invasion (Figure 3), which enhances apoptotic resistance and metastatic potential (18). Here, MRPL52 is linked to breast cancer.